Biotechnology Jobs

• Waltham, United States
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset, acting as the senior clinical voice on the Medicine Development Team core quad. Leads governance and investment discussions, Health Authority interactions and evidence-generation strategy, while directing Senior Scientists who handle study-level delivery. Hybrid role with at least two days per week on-site.

AI-enabled Insights · Data Platforms

• Stevenage
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset, acting as the senior clinical voice on the Medicine Development Team core quad. Leads governance and health authority interactions while directing Senior Scientists who handle study-level delivery, and mentors clinical development talent.

AI

• Waltham, United States
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory approval and initial launch. Acts as senior clinical representative at governance forums and leads cross-functional collaboration across research, precision medicine, medical affairs and commercial in a global matrix.

AI/ML

• Zug, Switzerland
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development of a multi-tumor oncology asset, from first-in-human through registrational trials, regulatory approval and launch. Leads cross-functional strategy with research, precision medicine, medical affairs and commercial partners, and represents the program at senior governance forums. Requires deep antibody-drug conjugate and global regulatory experience.

• London
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development strategy for a multi-tumor oncology asset, spanning first-in-human through registrational trials, regulatory filing and initial market launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams across research, precision medicine, medical affairs and commercial. Requires deep antibody-drug conjugate and global health authority experience.

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Accountable for end-to-end clinical development strategy for an antibody-drug conjugate asset across multiple tumour types, from first-in-human through registrational trials and launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial.

• Stevenage
• Director

Leads the development and execution of the analytical (QC testing) network strategy across GSK's global supply chain, translating approved strategy into an operational roadmap and securing endorsement from governance forums such as the Supply Chain Review Board. Drives benchmarking, KPI and reporting frameworks, and capability building across GSC Strategy, with focus on large molecules, ADCs and Oligos.

• Durham, United States
• US$148,500 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Establishes KPIs and reporting to track strategy impact and mitigate network risk.

• Waltham, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across GSK's global supply chain, translating approved strategy into operational roadmaps and securing governance endorsement. Partners with Quality, MSAT, R&D and product leads on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting and risk mitigation for large molecules, ADCs and Oligos.

• London
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Benchmarks industry practice and builds KPI reporting and capability within the GSC Strategy team.

• Zebulon, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across the global supply chain, translating approved strategy into an operational roadmap and securing endorsement from governance forums such as the Supply Chain Review Board. Partners with GSC Quality, MSAT and R&D on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Upper Merion
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Collaborates with GSC Quality, MSAT and R&D, benchmarks industry best practice, and establishes KPIs and reporting for senior leadership. Focuses on analytical testing strategy for large molecules, ADCs and Oligos.

• Belgium-Wavre
• €148,500 – €247,500 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's global supply chain, defining QC testing network principles and translating them into an operational roadmap. Acts as the single point of contact in GSC Strategy, collaborating with Quality, MSAT and R&D, benchmarking industry practice and reporting KPIs to senior leadership.

• London
• Hybrid

Provides technical leadership for structuring, connecting and reusing product and process data across digital products and manufacturing systems, with a focus on the digital product profile. Builds and maintains CI/CD pipelines, integrations and environments spanning R&D, CMC and commercial platforms, applying ontologies, knowledge graphs and AI-assisted engineering under GxP and Responsible AI controls.

PDLM · MES · LES/LIMS +5

• Stevenage
• Hybrid
• Director

Individual-contributor alliance lead owning the relationship with an established central laboratory partner, balancing strategic direction with day-to-day governance and delivery oversight. Embeds a new operating model, monitors KPIs and study delivery, resolves escalations, and uses AI tools such as Claude to analyse large datasets and drive continuous improvement.

Claude